Preparation and in vitro/in vivo characterization of sustained-release ciprofloxacin-carrageenan complex.


Journal

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
ISSN: 1873-3441
Titre abrégé: Eur J Pharm Biopharm
Pays: Netherlands
ID NLM: 9109778

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 07 07 2023
revised: 16 08 2023
accepted: 20 08 2023
medline: 2 10 2023
pubmed: 25 8 2023
entrez: 24 8 2023
Statut: ppublish

Résumé

The goal of the study was to look into drug-polyelectrolyte complexation between ciprofloxacin (Cipro) and λ-carrageenan (CRG), and to employ the complex as a sustained-release matrix. The maximum binding capacity of the complexation was determined using the dialysis bag method and employed to prepare the complex. In comparison to Cipro, CRG, and their physical mixing, the complex was examined using differential scanning calorimetry, Fourier infrared spectroscopy, powder X-ray diffraction, and scanning electron microscopy. Cipro-CRG matrices, manufactured as direct compression tablets based on the greatest binding capacity, were assessed for swelling, erosion and drug release in 0.1 M HCl, in comparison with those of CRG, Hydroxypropyl methylcellulose (HPMC) and Cipro-HPMC matrices. In vivo absorption study comparing the Cipro-CRG matrix to Cipro immediate-release tablet was also carried out. The greatest binding capacity of Cipro to CRG was 55% (w/w). Multiple interactions, including electrostatic interaction, Vander wall forces, and hydrogen bonding, have been proposed to be involved in complexation with drug amorphization. As a result of the complexation, the swelling and erosion properties of CRG changed, with Cipro-CRG matrix showing substantially less swelling and erosion than Cipro-free CRG matrix. Cipro-CRG matrix exhibited swelling and erosion similar to Cipro-HPMC matrix. However, the former matrix demonstrated Cipro release with significantly less burst impact and a significantly slower release rate. Furthermore, Cipro-CRG matrices in vivo demonstrated slow-prolonged oral drug absorption with consequent significant changes in pharmacokinetic parameters in comparison to those obtained for immediate-release tablets.

Identifiants

pubmed: 37619955
pii: S0939-6411(23)00215-1
doi: 10.1016/j.ejpb.2023.08.012
pii:
doi:

Substances chimiques

Carrageenan 9000-07-1
Delayed-Action Preparations 0
Tablets 0
Drug Carriers 0
Hypromellose Derivatives 3NXW29V3WO
Methylcellulose 9004-67-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

78-89

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Samaa Abdullah (S)

Health Sciences Research Centre, Princess Nourah bint Abdulrahman University, Riyadh 84428, Saudi Arabia. Electronic address: stabdullah@pnu.edu.sa.

Ahmad Bani-Jaber (A)

Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, The University of Jordan, Amman, Jordan. Electronic address: abjaber@ju.edu.jo.

Nabil A Alhakamy (NA)

Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia; Center of Excellence for Drug Research Pharmaceutical Industries, King Abdulaziz University, Jeddah, Saudi Arabia; Mohamed Saeed Tamer Chair for Pharmaceutical Industries, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.

Yahya F Jamous (YF)

The National Centre of Vaccines and Bioprocessing, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia.

Alaa A Al-Masud (AA)

Tissue Banking Section, Research Department, Health Science Research Center, Princess Nourah bint Abdulrahman University, Riyadh 84428, Saudi Arabia.

Meshal Marzoog Al-Sharafa (M)

Tissue Banking Section, Research Department, Health Science Research Center, Princess Nourah bint Abdulrahman University, Riyadh 84428, Saudi Arabia.

Articles similaires

Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.

Prashant Kesharwani, Kratika Halwai, Saurav Kumar Jha et al.
1.00
Chitosan Humans Folic Acid Nanoparticles Drug Carriers
Inclusion Bodies Solubility Recombinant Proteins Detergents Protein Denaturation
Nanoparticles Needles Polylactic Acid-Polyglycolic Acid Copolymer Polyethylene Glycols Curcumin
Administration, Intranasal Humans Animals Nasal Mucosa Brain

Classifications MeSH